2'-hydroxychalcone inhibits nuclear factor-κB and blocks tumor necrosis Factor-α- and lipopolysaccharide-induced adhesion of neutrophils to human umbilical vein endothelial cells

Madan, Babita ; Batra, Sanjay ; Ghosh, Balaram (2000) 2'-hydroxychalcone inhibits nuclear factor-κB and blocks tumor necrosis Factor-α- and lipopolysaccharide-induced adhesion of neutrophils to human umbilical vein endothelial cells Molecular Pharmacology, 58 (3). pp. 526-534. ISSN 0026-895X

Full text not available from this repository.

Official URL: http://molpharm.aspetjournals.org/content/58/3/526...

Abstract

Inhibition of expression of cell adhesion molecules (CAM), including intercellular CAM-1 (ICAM-1), vascular CAM-1 (VCAM-1), and E-selectin, has been shown to be important in controlling various inflammatory diseases. The cell adhesion proteins are induced by various inflammatory cytokines, such as tumor necrosis factor-α, interleukin-1, and bacterial lipopolysaccharide. The induction process primarily takes place at the level of transcription, where nuclear factor-κB (NF-κB) plays a major role. We demonstrate here that 2'-hydroxychalcone inhibits the adhesion of peripheral neutrophils to the endothelial cell monolayers by inhibiting the expression of ICAM-1, VCAM-1, and E-selectin in a concentration-dependent manner. The inhibition by 2'-hydroxychalcone is reversible. 2'-Hydroxychalcone inhibits the induction of steady-state transcript levels of ICAM-1, VCAM-1, and E-selectin by tumor necrosis factor-α as determined by reverse transcription-polymerase chain reaction, and therefore it may interfere with the transcription of their genes. Because NF-κB is a major transcription factor involved in CAM expression, we studied its status in the 2'-hydroxychalcone treated cells. We demonstrate that 2'-hydroxychalcone inhibits the activation of NF-κB. These results have implications for using NF-κB inhibitors for the treatment of various inflammatory diseases.

Item Type:Article
Source:Copyright of this article belongs to American Society for Pharmacology and Experimental Therapeutics.
ID Code:66066
Deposited On:21 Oct 2011 03:28
Last Modified:21 Oct 2011 03:28

Repository Staff Only: item control page